Sheridan E, Hancock B W, Goyns M H
Department of Clinical Oncology, Royal Hallamshire Hospital, Sheffield, UK.
Cancer Lett. 1993 Jan 15;68(1):83-9. doi: 10.1016/0304-3835(93)90223-v.
We have investigated a series of ovarian tumours for evidence of mutations in the p53 tumour suppressor gene. In this study we have made use of the chemical mismatch cleavage technique which, from analyses of other genes, has been shown to consistently identify all point mutations present within a region of DNA. This approach revealed mutations of p53 in 11/20 tumours studied, mainly in exons 5 or 7. After sequencing the relevant regions of the gene it was shown that ten of these mutations would have resulted in an amino acid substitution in the protein and only one represented a polymorphism. The observed incidence of p53 missense mutations in our series (50%) was the highest recorded in ovarian tumours and demonstrated the potential of the mismatch cleavage technique as a reliable method for the detection of p53 mutations in human tumours.
我们研究了一系列卵巢肿瘤,以寻找p53肿瘤抑制基因突变的证据。在本研究中,我们采用了化学错配切割技术,从对其他基因的分析来看,该技术已被证明能始终如一地识别出DNA区域内存在的所有点突变。这种方法在研究的20个肿瘤中有11个发现了p53突变,主要在外显子5或7中。对该基因的相关区域进行测序后发现,其中10个突变会导致蛋白质中的氨基酸替换,只有1个代表多态性。我们系列研究中观察到的p53错义突变发生率(50%)是卵巢肿瘤中记录到的最高值,证明了错配切割技术作为检测人类肿瘤中p53突变的可靠方法的潜力。